PMDA drug package insert
アップニークミニ点眼液0.1%
PMDA Prescription drug · 参天製薬株式会社 · package insert May 15, 2026
Key facts
| Brand names | アップニークミニ点眼液0.1% |
|---|---|
| Nonproprietary names | オキシメタゾリン塩酸塩 |
| Companies | 製造販売元／参天製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 後天性眼瞼下垂治療剤; （ミュラー筋作用・眼瞼挙上点眼薬） |
| Therapeutic category codes | 871319 |
| YJ codes | 131970CQ1020 |
| Approval numbers | 30700AMX00269 |
| Package insert edition | 第2版 |
| Package insert date | May 15, 2026 |
| PMDA document key | 300237_131970CQ1020_1 |
| PMDA company code | 300237 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: